- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
According to our latest study, the global mRNA Vaccines & Therapeutics market size was valued at USD 37740 million in 2022 and is forecast to a readjusted size of USD 13790 million by 2029 with a CAGR of -13.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core mRNA vaccines & therapeutics manufacturers include Moderna Therapeutics, CureVac etc. The top 3 companies hold a share about 65%. Europe is the largest market, with a share about 10%, followed by Asia Pacific and North America.
This report is a detailed and comprehensive analysis for global mRNA Vaccines & Therapeutics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global mRNA Vaccines & Therapeutics market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Doses), 2018-2029
Global mRNA Vaccines & Therapeutics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Doses), 2018-2029
Global mRNA Vaccines & Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Doses), 2018-2029
Global mRNA Vaccines & Therapeutics market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/Doses), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for mRNA Vaccines & Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global mRNA Vaccines & Therapeutics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna Therapeutics, CureVac, Translate Bio, BioNTech and Sangamo Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
mRNA Vaccines & Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Infectious Disease Vaccines
Cancer Vaccines
Market segment by Application
Infectious Disease
Cancer
Major players covered
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe mRNA Vaccines & Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of mRNA Vaccines & Therapeutics, with price, sales, revenue and global market share of mRNA Vaccines & Therapeutics from 2018 to 2023.
Chapter 3, the mRNA Vaccines & Therapeutics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the mRNA Vaccines & Therapeutics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and mRNA Vaccines & Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of mRNA Vaccines & Therapeutics.
Chapter 14 and 15, to describe mRNA Vaccines & Therapeutics sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of mRNA Vaccines & Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global mRNA Vaccines & Therapeutics Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Infectious Disease Vaccines
1.3.3 Cancer Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global mRNA Vaccines & Therapeutics Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Infectious Disease
1.4.3 Cancer
1.5 Global mRNA Vaccines & Therapeutics Market Size & Forecast
1.5.1 Global mRNA Vaccines & Therapeutics Consumption Value (2018 & 2022 & 2029)
1.5.2 Global mRNA Vaccines & Therapeutics Sales Quantity (2018-2029)
1.5.3 Global mRNA Vaccines & Therapeutics Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Moderna Therapeutics
2.1.1 Moderna Therapeutics Details
2.1.2 Moderna Therapeutics Major Business
2.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Product and Services
2.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Moderna Therapeutics Recent Developments/Updates
2.2 CureVac
2.2.1 CureVac Details
2.2.2 CureVac Major Business
2.2.3 CureVac mRNA Vaccines & Therapeutics Product and Services
2.2.4 CureVac mRNA Vaccines & Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CureVac Recent Developments/Updates
2.3 Translate Bio
2.3.1 Translate Bio Details
2.3.2 Translate Bio Major Business
2.3.3 Translate Bio mRNA Vaccines & Therapeutics Product and Services
2.3.4 Translate Bio mRNA Vaccines & Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Translate Bio Recent Developments/Updates
2.4 BioNTech
2.4.1 BioNTech Details
2.4.2 BioNTech Major Business
2.4.3 BioNTech mRNA Vaccines & Therapeutics Product and Services
2.4.4 BioNTech mRNA Vaccines & Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 BioNTech Recent Developments/Updates
2.5 Sangamo Therapeutics
2.5.1 Sangamo Therapeutics Details
2.5.2 Sangamo Therapeutics Major Business
2.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product and Services
2.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sangamo Therapeutics Recent Developments/Updates
2.6 Argos Therapeutics
2.6.1 Argos Therapeutics Details
2.6.2 Argos Therapeutics Major Business
2.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Product and Services
2.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Argos Therapeutics Recent Developments/Updates
2.7 In-Cell-Art
2.7.1 In-Cell-Art Details
2.7.2 In-Cell-Art Major Business
2.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Product and Services
2.7.4 In-Cell-Art mRNA Vaccines & Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 In-Cell-Art Recent Developments/Updates
2.8 eTheRNA
2.8.1 eTheRNA Details
2.8.2 eTheRNA Major Business
2.8.3 eTheRNA mRNA Vaccines & Therapeutics Product and Services
2.8.4 eTheRNA mRNA Vaccines & Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 eTheRNA Recent Developments/Updates
2.9 Ethris
2.9.1 Ethris Details
2.9.2 Ethris Major Business
2.9.3 Ethris mRNA Vaccines & Therapeutics Product and Services
2.9.4 Ethris mRNA Vaccines & Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Ethris Recent Developments/Updates
2.10 Tiba Biotechnology
2.10.1 Tiba Biotechnology Details
2.10.2 Tiba Biotechnology Major Business
2.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Product and Services
2.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Tiba Biotechnology Recent Developments/Updates
3 Competitive Environment: mRNA Vaccines & Therapeutics by Manufacturer
3.1 Global mRNA Vaccines & Therapeutics Sales Quantity by Manufacturer (2018-2023)
3.2 Global mRNA Vaccines & Therapeutics Revenue by Manufacturer (2018-2023)
3.3 Global mRNA Vaccines & Therapeutics Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of mRNA Vaccines & Therapeutics by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2022
3.4.2 Top 6 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2022
3.5 mRNA Vaccines & Therapeutics Market: Overall Company Footprint Analysis
3.5.1 mRNA Vaccines & Therapeutics Market: Region Footprint
3.5.2 mRNA Vaccines & Therapeutics Market: Company Product Type Footprint
3.5.3 mRNA Vaccines & Therapeutics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global mRNA Vaccines & Therapeutics Market Size by Region
4.1.1 Global mRNA Vaccines & Therapeutics Sales Quantity by Region (2018-2029)
4.1.2 Global mRNA Vaccines & Therapeutics Consumption Value by Region (2018-2029)
4.1.3 Global mRNA Vaccines & Therapeutics Average Price by Region (2018-2029)
4.2 North America mRNA Vaccines & Therapeutics Consumption Value (2018-2029)
4.3 Europe mRNA Vaccines & Therapeutics Consumption Value (2018-2029)
4.4 Asia-Pacific mRNA Vaccines & Therapeutics Consumption Value (2018-2029)
4.5 South America mRNA Vaccines & Therapeutics Consumption Value (2018-2029)
4.6 Middle East and Africa mRNA Vaccines & Therapeutics Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global mRNA Vaccines & Therapeutics Sales Quantity by Type (2018-2029)
5.2 Global mRNA Vaccines & Therapeutics Consumption Value by Type (2018-2029)
5.3 Global mRNA Vaccines & Therapeutics Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global mRNA Vaccines & Therapeutics Sales Quantity by Application (2018-2029)
6.2 Global mRNA Vaccines & Therapeutics Consumption Value by Application (2018-2029)
6.3 Global mRNA Vaccines & Therapeutics Average Price by Application (2018-2029)
7 North America
7.1 North America mRNA Vaccines & Therapeutics Sales Quantity by Type (2018-2029)
7.2 North America mRNA Vaccines & Therapeutics Sales Quantity by Application (2018-2029)
7.3 North America mRNA Vaccines & Therapeutics Market Size by Country
7.3.1 North America mRNA Vaccines & Therapeutics Sales Quantity by Country (2018-2029)
7.3.2 North America mRNA Vaccines & Therapeutics Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe mRNA Vaccines & Therapeutics Sales Quantity by Type (2018-2029)
8.2 Europe mRNA Vaccines & Therapeutics Sales Quantity by Application (2018-2029)
8.3 Europe mRNA Vaccines & Therapeutics Market Size by Country
8.3.1 Europe mRNA Vaccines & Therapeutics Sales Quantity by Country (2018-2029)
8.3.2 Europe mRNA Vaccines & Therapeutics Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific mRNA Vaccines & Therapeutics Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific mRNA Vaccines & Therapeutics Market Size by Region
9.3.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific mRNA Vaccines & Therapeutics Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America mRNA Vaccines & Therapeutics Sales Quantity by Type (2018-2029)
10.2 South America mRNA Vaccines & Therapeutics Sales Quantity by Application (2018-2029)
10.3 South America mRNA Vaccines & Therapeutics Market Size by Country
10.3.1 South America mRNA Vaccines & Therapeutics Sales Quantity by Country (2018-2029)
10.3.2 South America mRNA Vaccines & Therapeutics Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa mRNA Vaccines & Therapeutics Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa mRNA Vaccines & Therapeutics Market Size by Country
11.3.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa mRNA Vaccines & Therapeutics Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 mRNA Vaccines & Therapeutics Market Drivers
12.2 mRNA Vaccines & Therapeutics Market Restraints
12.3 mRNA Vaccines & Therapeutics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of mRNA Vaccines & Therapeutics and Key Manufacturers
13.2 Manufacturing Costs Percentage of mRNA Vaccines & Therapeutics
13.3 mRNA Vaccines & Therapeutics Production Process
13.4 mRNA Vaccines & Therapeutics Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 mRNA Vaccines & Therapeutics Typical Distributors
14.3 mRNA Vaccines & Therapeutics Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global mRNA Vaccines & Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global mRNA Vaccines & Therapeutics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Moderna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 4. Moderna Therapeutics Major Business
Table 5. Moderna Therapeutics mRNA Vaccines & Therapeutics Product and Services
Table 6. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Moderna Therapeutics Recent Developments/Updates
Table 8. CureVac Basic Information, Manufacturing Base and Competitors
Table 9. CureVac Major Business
Table 10. CureVac mRNA Vaccines & Therapeutics Product and Services
Table 11. CureVac mRNA Vaccines & Therapeutics Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. CureVac Recent Developments/Updates
Table 13. Translate Bio Basic Information, Manufacturing Base and Competitors
Table 14. Translate Bio Major Business
Table 15. Translate Bio mRNA Vaccines & Therapeutics Product and Services
Table 16. Translate Bio mRNA Vaccines & Therapeutics Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Translate Bio Recent Developments/Updates
Table 18. BioNTech Basic Information, Manufacturing Base and Competitors
Table 19. BioNTech Major Business
Table 20. BioNTech mRNA Vaccines & Therapeutics Product and Services
Table 21. BioNTech mRNA Vaccines & Therapeutics Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. BioNTech Recent Developments/Updates
Table 23. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Sangamo Therapeutics Major Business
Table 25. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product and Services
Table 26. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sangamo Therapeutics Recent Developments/Updates
Table 28. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table 29. Argos Therapeutics Major Business
Table 30. Argos Therapeutics mRNA Vaccines & Therapeutics Product and Services
Table 31. Argos Therapeutics mRNA Vaccines & Therapeutics Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Argos Therapeutics Recent Developments/Updates
Table 33. In-Cell-Art Basic Information, Manufacturing Base and Competitors
Table 34. In-Cell-Art Major Business
Table 35. In-Cell-Art mRNA Vaccines & Therapeutics Product and Services
Table 36. In-Cell-Art mRNA Vaccines & Therapeutics Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. In-Cell-Art Recent Developments/Updates
Table 38. eTheRNA Basic Information, Manufacturing Base and Competitors
Table 39. eTheRNA Major Business
Table 40. eTheRNA mRNA Vaccines & Therapeutics Product and Services
Table 41. eTheRNA mRNA Vaccines & Therapeutics Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. eTheRNA Recent Developments/Updates
Table 43. Ethris Basic Information, Manufacturing Base and Competitors
Table 44. Ethris Major Business
Table 45. Ethris mRNA Vaccines & Therapeutics Product and Services
Table 46. Ethris mRNA Vaccines & Therapeutics Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Ethris Recent Developments/Updates
Table 48. Tiba Biotechnology Basic Information, Manufacturing Base and Competitors
Table 49. Tiba Biotechnology Major Business
Table 50. Tiba Biotechnology mRNA Vaccines & Therapeutics Product and Services
Table 51. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Tiba Biotechnology Recent Developments/Updates
Table 53. Global mRNA Vaccines & Therapeutics Sales Quantity by Manufacturer (2018-2023) & (M Doses)
Table 54. Global mRNA Vaccines & Therapeutics Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global mRNA Vaccines & Therapeutics Average Price by Manufacturer (2018-2023) & (USD/Doses)
Table 56. Market Position of Manufacturers in mRNA Vaccines & Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and mRNA Vaccines & Therapeutics Production Site of Key Manufacturer
Table 58. mRNA Vaccines & Therapeutics Market: Company Product Type Footprint
Table 59. mRNA Vaccines & Therapeutics Market: Company Product Application Footprint
Table 60. mRNA Vaccines & Therapeutics New Market Entrants and Barriers to Market Entry
Table 61. mRNA Vaccines & Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global mRNA Vaccines & Therapeutics Sales Quantity by Region (2018-2023) & (M Doses)
Table 63. Global mRNA Vaccines & Therapeutics Sales Quantity by Region (2024-2029) & (M Doses)
Table 64. Global mRNA Vaccines & Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global mRNA Vaccines & Therapeutics Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global mRNA Vaccines & Therapeutics Average Price by Region (2018-2023) & (USD/Doses)
Table 67. Global mRNA Vaccines & Therapeutics Average Price by Region (2024-2029) & (USD/Doses)
Table 68. Global mRNA Vaccines & Therapeutics Sales Quantity by Type (2018-2023) & (M Doses)
Table 69. Global mRNA Vaccines & Therapeutics Sales Quantity by Type (2024-2029) & (M Doses)
Table 70. Global mRNA Vaccines & Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global mRNA Vaccines & Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global mRNA Vaccines & Therapeutics Average Price by Type (2018-2023) & (USD/Doses)
Table 73. Global mRNA Vaccines & Therapeutics Average Price by Type (2024-2029) & (USD/Doses)
Table 74. Global mRNA Vaccines & Therapeutics Sales Quantity by Application (2018-2023) & (M Doses)
Table 75. Global mRNA Vaccines & Therapeutics Sales Quantity by Application (2024-2029) & (M Doses)
Table 76. Global mRNA Vaccines & Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global mRNA Vaccines & Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global mRNA Vaccines & Therapeutics Average Price by Application (2018-2023) & (USD/Doses)
Table 79. Global mRNA Vaccines & Therapeutics Average Price by Application (2024-2029) & (USD/Doses)
Table 80. North America mRNA Vaccines & Therapeutics Sales Quantity by Type (2018-2023) & (M Doses)
Table 81. North America mRNA Vaccines & Therapeutics Sales Quantity by Type (2024-2029) & (M Doses)
Table 82. North America mRNA Vaccines & Therapeutics Sales Quantity by Application (2018-2023) & (M Doses)
Table 83. North America mRNA Vaccines & Therapeutics Sales Quantity by Application (2024-2029) & (M Doses)
Table 84. North America mRNA Vaccines & Therapeutics Sales Quantity by Country (2018-2023) & (M Doses)
Table 85. North America mRNA Vaccines & Therapeutics Sales Quantity by Country (2024-2029) & (M Doses)
Table 86. North America mRNA Vaccines & Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America mRNA Vaccines & Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe mRNA Vaccines & Therapeutics Sales Quantity by Type (2018-2023) & (M Doses)
Table 89. Europe mRNA Vaccines & Therapeutics Sales Quantity by Type (2024-2029) & (M Doses)
Table 90. Europe mRNA Vaccines & Therapeutics Sales Quantity by Application (2018-2023) & (M Doses)
Table 91. Europe mRNA Vaccines & Therapeutics Sales Quantity by Application (2024-2029) & (M Doses)
Table 92. Europe mRNA Vaccines & Therapeutics Sales Quantity by Country (2018-2023) & (M Doses)
Table 93. Europe mRNA Vaccines & Therapeutics Sales Quantity by Country (2024-2029) & (M Doses)
Table 94. Europe mRNA Vaccines & Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe mRNA Vaccines & Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific mRNA Vaccines & Therapeutics Sales Quantity by Type (2018-2023) & (M Doses)
Table 97. Asia-Pacific mRNA Vaccines & Therapeutics Sales Quantity by Type (2024-2029) & (M Doses)
Table 98. Asia-Pacific mRNA Vaccines & Therapeutics Sales Quantity by Application (2018-2023) & (M Doses)
Table 99. Asia-Pacific mRNA Vaccines & Therapeutics Sales Quantity by Application (2024-2029) & (M Doses)
Table 100. Asia-Pacific mRNA Vaccines & Therapeutics Sales Quantity by Region (2018-2023) & (M Doses)
Table 101. Asia-Pacific mRNA Vaccines & Therapeutics Sales Quantity by Region (2024-2029) & (M Doses)
Table 102. Asia-Pacific mRNA Vaccines & Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific mRNA Vaccines & Therapeutics Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America mRNA Vaccines & Therapeutics Sales Quantity by Type (2018-2023) & (M Doses)
Table 105. South America mRNA Vaccines & Therapeutics Sales Quantity by Type (2024-2029) & (M Doses)
Table 106. South America mRNA Vaccines & Therapeutics Sales Quantity by Application (2018-2023) & (M Doses)
Table 107. South America mRNA Vaccines & Therapeutics Sales Quantity by Application (2024-2029) & (M Doses)
Table 108. South America mRNA Vaccines & Therapeutics Sales Quantity by Country (2018-2023) & (M Doses)
Table 109. South America mRNA Vaccines & Therapeutics Sales Quantity by Country (2024-2029) & (M Doses)
Table 110. South America mRNA Vaccines & Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America mRNA Vaccines & Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa mRNA Vaccines & Therapeutics Sales Quantity by Type (2018-2023) & (M Doses)
Table 113. Middle East & Africa mRNA Vaccines & Therapeutics Sales Quantity by Type (2024-2029) & (M Doses)
Table 114. Middle East & Africa mRNA Vaccines & Therapeutics Sales Quantity by Application (2018-2023) & (M Doses)
Table 115. Middle East & Africa mRNA Vaccines & Therapeutics Sales Quantity by Application (2024-2029) & (M Doses)
Table 116. Middle East & Africa mRNA Vaccines & Therapeutics Sales Quantity by Region (2018-2023) & (M Doses)
Table 117. Middle East & Africa mRNA Vaccines & Therapeutics Sales Quantity by Region (2024-2029) & (M Doses)
Table 118. Middle East & Africa mRNA Vaccines & Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa mRNA Vaccines & Therapeutics Consumption Value by Region (2024-2029) & (USD Million)
Table 120. mRNA Vaccines & Therapeutics Raw Material
Table 121. Key Manufacturers of mRNA Vaccines & Therapeutics Raw Materials
Table 122. mRNA Vaccines & Therapeutics Typical Distributors
Table 123. mRNA Vaccines & Therapeutics Typical Customers
List of Figures
Figure 1. mRNA Vaccines & Therapeutics Picture
Figure 2. Global mRNA Vaccines & Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global mRNA Vaccines & Therapeutics Consumption Value Market Share by Type in 2022
Figure 4. Infectious Disease Vaccines Examples
Figure 5. Cancer Vaccines Examples
Figure 6. Global mRNA Vaccines & Therapeutics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global mRNA Vaccines & Therapeutics Consumption Value Market Share by Application in 2022
Figure 8. Infectious Disease Examples
Figure 9. Cancer Examples
Figure 10. Global mRNA Vaccines & Therapeutics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global mRNA Vaccines & Therapeutics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global mRNA Vaccines & Therapeutics Sales Quantity (2018-2029) & (M Doses)
Figure 13. Global mRNA Vaccines & Therapeutics Average Price (2018-2029) & (USD/Doses)
Figure 14. Global mRNA Vaccines & Therapeutics Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global mRNA Vaccines & Therapeutics Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of mRNA Vaccines & Therapeutics by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 mRNA Vaccines & Therapeutics Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 mRNA Vaccines & Therapeutics Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global mRNA Vaccines & Therapeutics Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global mRNA Vaccines & Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 21. North America mRNA Vaccines & Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe mRNA Vaccines & Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific mRNA Vaccines & Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 24. South America mRNA Vaccines & Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa mRNA Vaccines & Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 26. Global mRNA Vaccines & Therapeutics Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global mRNA Vaccines & Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 28. Global mRNA Vaccines & Therapeutics Average Price by Type (2018-2029) & (USD/Doses)
Figure 29. Global mRNA Vaccines & Therapeutics Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global mRNA Vaccines & Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 31. Global mRNA Vaccines & Therapeutics Average Price by Application (2018-2029) & (USD/Doses)
Figure 32. North America mRNA Vaccines & Therapeutics Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America mRNA Vaccines & Therapeutics Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America mRNA Vaccines & Therapeutics Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America mRNA Vaccines & Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 36. United States mRNA Vaccines & Therapeutics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada mRNA Vaccines & Therapeutics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico mRNA Vaccines & Therapeutics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe mRNA Vaccines & Therapeutics Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe mRNA Vaccines & Therapeutics Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe mRNA Vaccines & Therapeutics Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe mRNA Vaccines & Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany mRNA Vaccines & Therapeutics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France mRNA Vaccines & Therapeutics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom mRNA Vaccines & Therapeutics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia mRNA Vaccines & Therapeutics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy mRNA Vaccines & Therapeutics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific mRNA Vaccines & Therapeutics Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific mRNA Vaccines & Therapeutics Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific mRNA Vaccines & Therapeutics Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific mRNA Vaccines & Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 52. China mRNA Vaccines & Therapeutics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan mRNA Vaccines & Therapeutics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea mRNA Vaccines & Therapeutics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India mRNA Vaccines & Therapeutics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia mRNA Vaccines & Therapeutics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia mRNA Vaccines & Therapeutics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America mRNA Vaccines & Therapeutics Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America mRNA Vaccines & Therapeutics Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America mRNA Vaccines & Therapeutics Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America mRNA Vaccines & Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil mRNA Vaccines & Therapeutics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina mRNA Vaccines & Therapeutics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa mRNA Vaccines & Therapeutics Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa mRNA Vaccines & Therapeutics Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa mRNA Vaccines & Therapeutics Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa mRNA Vaccines & Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey mRNA Vaccines & Therapeutics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt mRNA Vaccines & Therapeutics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia mRNA Vaccines & Therapeutics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa mRNA Vaccines & Therapeutics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. mRNA Vaccines & Therapeutics Market Drivers
Figure 73. mRNA Vaccines & Therapeutics Market Restraints
Figure 74. mRNA Vaccines & Therapeutics Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of mRNA Vaccines & Therapeutics in 2022
Figure 77. Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
Figure 78. mRNA Vaccines & Therapeutics Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
